Global Peri-implantitis Market by Method Type (Surgical, Non-surgical) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast To 2028

Summary of the Report

Global peri-implantitis was worth USD 0.71 billion in 2019. It is projected to grow at an 8.7% compound annual growth rate (CAGR), between 2020 and 2027. A site-specific infectious disease, peri-implantitis causes inflammation in the soft tissues and bone loss around an implant. Osseointegrated implants are becoming a more popular option for replacing missing or damaged teeth. When used to support different types of dental prostheses, dental implants are known for their long-term survival rates (greater than 10 year). The long-term survival rate of dental implants may not be as good as the rates of their survival. Functional implants and their restorations can be affected by biological and mechanical complications.

Poor oral hygiene, smoking, diabetes, and biomechanical overload are all factors that can increase your risk of developing peri-implantitis. As dental treatment options have increased in popularity, periimplant mucositis and periimplantitis are also more common. These conditions can cause damage to the implant function and bone loss in the tissue surrounding it. Depending on the extent of bone loss in the implanted teeth, peri-implantitis can be divided into four stages. The dentist will determine the best treatment plan based on the extent of bone loss. Unfortunately, radiographs can only detect bone loss if 30% or more of the bone mass has been lost. This can lead to difficult early detection.

The prevalence of periimplantitis in the United States was 34% at the patient level, and 21% at the implant level. This average follow-up period of 2 years was reported by NCBI. A major contributor to the rise in demand for dental implant is the rising popularity of peri-implantitis. Peri-implantitis is more common in people with a history of periodontal diseases. The CDC estimates that 47.2% of Americans aged 30 have some form periodontal disease. This condition is more common in men than in women, as they are more likely to smoke and have other health problems like diabetes.

Modern technological advances such as mechanical debridement and laser decontamination, surgical bridement with guided bony regeneration (GBR), for the treatment of boney and soft-tissue defect repair, and diagnostic genetic biomarker technologies have led to improved clinical outcomes and selective calcium removal. These factors will likely increase the market for peri-implantitis treatments.

Method Type Insights

In 2019, the surgical segment held the largest revenue share at 58.0% and dominated the market in peri-implantitis. This segment is expected to see a significant increase in CAGR during the forecast period. The market can be divided into surgical and non-surgical types based on its method type. The surgical method can be further divided into open flap debridement and implantoplasty. Non-surgical methods can be sub-segmented to include laser debridement and mechanical debridement. Peri-implantitis can be treated with the surgical method, which provides comprehensive decontamination and debridement of the affected implants. The highest CAGR for peri-implantitis treatment is seen in resective surgery, or surgical bone regeneration. This procedure provides promising results and encourages patients to seek treatment.

As lasers are able to efficiently treat small areas of implant surface that cannot be reached by mechanical methods, the segment laser debridement nonsurgical method is expected to see the greatest CAGR. Diode lasers offer clinically significant reductions in pocket-probing depth, clinical attachment levels and complete elimination of bacteria. Because of its non-invasive nature and shorter recovery times, these non-surgical methods are rapidly gaining popularity.

Regional Insights

Europe was the dominant market for peri-implanttitis in 2019, accounting for 40.0% of the total revenue. This is expected to continue with a substantial CAGR over the forecast period. This can be attributed to the increasing number of patients with periodontal disease, technological advances, and the growing awareness about dental implant and related diseases among the population. Patients with severe periodontal conditions that affect the support structures of their teeth and require dental implants are covered by the European National Health Services. These are just a few of the reasons for the rapid growth of the peri-implantitis market in the region.

APAC is expected to see the highest CAGR at 10.7% during the forecast period. This is due to the large population, positive government initiatives and the availability of well-developed health care facilities. Dental Implants (DIs), which are used to replace missing teeth in populous countries such as India and China, are becoming more popular. India and China are the two largest countries that produce and consume tobacco, and have the lowest levels of smoking awareness. These are the key factors expected to increase the market for periimplantitis treatment in the region.

Market Share Insights & Key Companies

Peri-implantitis market is very competitive. The rapid technological advancements in anti-infective drug and solution development is a key factor in market competitiveness. Many companies have formed partnerships to help them develop new drugs and get their products to the market faster. Pfizer purchased the rights to AstraZeneca’s small-molecule anti-invectives company, primarily in the U.S., for USD 1.0 billion in January 2017. The following are some of the most prominent players in the global market for peri-implantitis:

• Pfizer Inc.

• Cadila Pharmaceuticals

• R.N. Laboratories Pvt. Ltd.

• Basic Pharma Life Science Pvt. Ltd.

• Prachi Pharmaceuticals Private Limited.

• Geistlich Pharma Inc.

• Healthy Life Pharma

Up Market Research published a new report titled “Peri-implantitis Market research report which is segmented by Method Type (Surgical, Non-surgical), By Players/Companies Prachi Pharmaceuticals Private Limited, RN Laboratories Pvt Ltd, Basic Pharma Life Science Pvt Ltd, Cadila Pharmaceuticals, Pfizer Inc, Healthy Life Pharma, Geistlich Pharma Inc”. As per the study the market is expected to grow at a CAGR of XX% in the forecast period.

Report Scope

The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.

Global Peri-implantitis Market Report Segments:

The market is segmented by Method Type (Surgical, Non-surgical).

Peri-implantitis Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.

Key Benefits for Industry Participants & Stakeholders:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Peri-implantitis Market

Overview of the regional outlook of the Peri-implantitis Market:

Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.

Highlights of The Peri-implantitis Market Report:

1. The market structure and projections for the coming years.
2. Drivers, restraints, opportunities, and current trends of Peri-implantitis Market.
3. Historical data and forecast.
4. Estimations for the forecast period 2028.
5. Developments and trends in the market.

                1. Surgical

                2. Non-surgical

7. Market scenario by region, sub-region, and country.
8. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
9. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
10. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Peri-implantitis Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.

How you may use our products:

• Correctly Positioning New Products
• Market Entry Strategies
• Business Expansion Strategies
• Consumer Insights
• Understanding Competition Scenario
• Product & Brand Management
• Channel & Customer Management
• Identifying Appropriate Advertising Appeals

Reasons to Purchase the Peri-implantitis Market Report:

• The report includes a plethora of information such as market dynamics scenario and opportunities during the forecast period
• Segments and sub-segments include quantitative, qualitative, value (USD Million,) and volume (Units Million) data.
• Regional, sub-regional, and country level data includes the demand and supply forces along with their influence on the market.
• The competitive landscape comprises share of key players, new developments, and strategies in the last three years.
• Comprehensive companies offering products, relevant financial information, recent developments, SWOT analysis, and strategies by these players.